Simethicone for the Preparation before Esophagogastroduodenoscopy
Majid Ahsan, Leila Babaei, Ali Gholamrezaei, Mohammad Hassan Emami, Majid Ahsan, Leila Babaei, Ali Gholamrezaei, Mohammad Hassan Emami
Abstract
Aim. The presence of air bubbles and foam in stomach and duodenum is a common problem during esophagogastroduodenoscopy (EGD). Methods. Candidates of elective EGD received 40 mg chewable tablet of simethicone (n = 90) or placebo (n = 83), with 30 mL water, 15-30 min before the EGD. Foam/air bubbles during endoscopy were assessed and graded on a 4-point scale, and patients' satisfaction with the endoscopy was scored from 0 to 10. Results. The amount of gastric but not duodenal foam/air bubbles was significantly lower in the simethicone group compared with the placebo group (P = 0.002). Duration of endoscopy was, on average, one minute shorter in the simethicone group compared with the placebo group (P < 0.001). Patients' satisfaction with the procedure was the same in the two groups. Conclusion. Administration of simethicone prior to EGD reduces the amount of gastric foam and bubbles and provides better visibility for evaluating the mucosa. It also decreases the duration of endoscopy. Further trials are required to find the final effect of the drug on diagnosis of pathological lesions.
Figures
References
- Cohen J, Safdi MA, Deal SE, et al. Quality indicators for esophagogastroduodenoscopy. American Journal of Gastroenterology. 2006;101(4):886–891.
- Kwan V, Devière J. Endoscopy essentials: preparation, sedation, and surveillance. Endoscopy. 2008;40(1):65–70.
- Enns R. Capsule endoscopy: in search of the ideal image. American Journal of Gastroenterology. 2008;103(1):83–85.
- Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients with suspected small intestinal bleeding: results of a pilot study. Gastrointestinal Endoscopy. 2002;56(3):349–353.
- Brecevic L, Bosan-Kilibarda I, Strajnar F. Mechanism of antifoaming action of simethicone. Journal of Applied Toxicology. 1994;14(3):207–211.
- Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Alimentary Pharmacology and Therapeutics. 2002;16(9):1641–1648.
- Wu L, Cao Y, Liao C, Huang J, Gao F. Systematic review and meta-analysis of randomized controlled trials of Simethicone for gastrointestinal endoscopic visibility. Scandinavian Journal of Gastroenterology. 2010;46:227–235.
- Sudduth RH, DeAngelis S, Sherman KE, McNally PR. The effectiveness of simethicone in improving visibility during colonoscopy when given with a sodium phosphate solution: a double-blind randomized study. Gastrointestinal Endoscopy. 1995;42(5):413–415.
- Saghaei M. Random allocation software for parallel group randomized trials. BMC Medical Research Methodology. 2004;4, article 26
- Banerjee B, Parker J, Waits W, Davis B. Effectiveness of preprocedure simethicone drink in improving visibility during esophagogastroduodenoscopy: a double-blind, randomized study. Journal of Clinical Gastroenterology. 1992;15(3):264–265.
- Bertoni G, Gumina C, Conigliaro R, et al. Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy. 1992;24(4):268–270.
- Keeratichananont S, Sobhonslidsuk A, Kitiyakara T, Achalanan N, Soonthornpun S. The role of liquid simethicone in enhancing endoscopic visibility prior to esophagogastroduodenoscopy (EGD): a prospective, randomized, double-blinded, placebo-controlled trial. Journal of the Medical Association of Thailand. 2010;93(8):892–897.
Source: PubMed